ArticleGlobal challenges (Hoboken, NJ)2024
Understanding the Role of Controlled Environments for Producing Mycelium-bound Composites: Advancing Circular Practices for Integrating Biotechnology into the Construction Industry.
Article in Global challenges (Hoboken, NJ), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Mycogenic Nanomaterials: What Fungal Nanoparticles Promise and What Still Holds Them Back.Journal of fungi (Basel, Switzerland) · 2026Review
- A closed-loop tray bioreactor for online monitoring of mycelium-based composites.Frontiers in microbiology · 2026Article
- Fungal Innovations-Advancing Sustainable Materials, Genetics, and Applications for Industry.Journal of fungi (Basel, Switzerland) · 2025Review
- Bioelectricity harvesting from microorganism: review of recent advancements in utilizing the bioelectric properties of fungi for powering small-scale robotic systems.Frontiers in fungal biology · 2025Review
- Understanding the Role of Controlled Environments for Producing Mycelium-bound Composites: Advancing Circular Practices for Integrating Biotechnology into the Construction Industry.Global challenges (Hoboken, NJ) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The architecture, engineering, and construction industry is undergoing a significant shift, steering buildings away from resource-intensive processes toward becoming instruments for climate mitigation. In this transformative landscape, integrating circular bio-based alternatives and reducing emissions through biotechnological and enzymatic processes have significant potential. Specifically, mycelium-bound composites have emerged as renewable alternatives for new materials and added-value wood products. Despite their numerous advantages, integrating these materials into current engineering practices presents challenges deriving from the complex nature of the material´s production process and the transfer from the laboratory to the industrial scale. In this regard, the design and engineering of novel controlled environments are fundamental in maintaining optimal growth conditions during material production. This, in turn, influences the overall material performance and potential use in construction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.